air bubble in semaglutide injection GLP-1 Syringe: Safety Facts and Removal Guide Air Bubble in Subcutaneous Injection:
Description
Monthly weight loss during this period often runs 4-6% of remaining body weight
Semaglutide is an antidiabetic drug that also has weight loss benefits
Given the broad use of GLP-1 drugs, the scope of this MDL could reach tens of thousands of claims in 2025
In the 104-week extension (baseline BMI 35), patients on 12 mg lost an average of 85 lbs (30.3%) and weight was still falling, with no plateau
